---
title: "Narrow-band TL-01 Phototherapy and Skin Cancer Risk: Nested Case–Control Analysis"
id: "pubmed-42713961"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42713961"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42713961/"
doi: "10.2340/actadv.v106.adv-2025-0274"
published_at: "2026-09-09T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Narrow-band TL-01 Phototherapy and Skin Cancer Risk: Nested Case–Control Analysis
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42713961
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42713961/)
- **DOI:** [10.2340/actadv.v106.adv-2025-0274](https://doi.org/10.2340%2Factadv.v106.adv-2025-0274)
- **Published At:** 2026-09-09T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- This nested case-control study evaluated the association between **narrow-band TL-01 UV-B phototherapy** exposure and subsequent skin cancer risk within a Finnish cohort of 4,815 patients treated with TL-01 monotherapy. - Personal TL-01 exposure data were extracted from hospital records. - Outcomes included 38 cases of **basal cell carcinoma (BCC)**, 13 cases of cutaneous melanoma, and 9 cases of cutaneous squamous cell carcinoma (cSCC). - For each skin cancer case, four matched controls were selected. - Conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). - An exposure–response relationship was observed for **basal cell carcinoma**: OR per 20 TL-01 sessions was 1.36 (95% CI 1.08–1.72). - In categorical analysis (reference 1–29 sessions), patients receiving ≥60 sessions had a markedly higher risk of BCC (OR 4.16, 95% CI 1.49–11.6). - No association between TL-01 exposure and cutaneous melanoma or cutaneous squamous cell carcinoma was found. - Occupational outdoor work was examined as a potential confounder but did not alter the observed associations. - Authors conclude that larger cohorts and longer follow-up are needed to confirm the BCC findings and to further assess risk for other skin cancer types.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42713961/#article-details) ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42713961%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42713961/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42713961/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42713961/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/c24ab723-7c80-48cd-9c68-022ded852586/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42713961/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42713961/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42713961/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42713961%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42713961%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42713961/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42713961/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42713961/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42713961/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42713961/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42713961/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42713961/#abstract) * [Similar articles](https://pubmed.ncbi.nlm.nih.gov/42713961/#similar) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/42713961/#mesh-terms) Title & authors Abstract Similar articles MeSH terms Acta Derm Venereol Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Acta+Derm+Venereol%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Acta+Derm+Venereol%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42713961/) . 2026 Sep 9:106. doi: 10.2340/actadv.v106.adv-2025-0274. # Narrow-band UV-B (TL-01) Phototherapy Exposure and Skin Cancer Risk: A Nested Case-control Study [Petra Åkerla](https://pubmed.ncbi.nlm.nih.gov/?term=%C3%85kerla+P&cauthor_id=42713961)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42713961/#full-view-affiliation-1 "Department of Dermatology, Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. petra.akerla@tuni.fi."), [Eero Pukkala](https://pubmed.ncbi.nlm.nih.gov/?term=Pukkala+E&cauthor_id=42713961)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42713961/#full-view-affiliation-2 "Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland; Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland."), [Mika Helminen](https://pubmed.ncbi.nlm.nih.gov/?term=Helminen+M&cauthor_id=42713961)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42713961/#full-view-affiliation-3 "Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland; Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland."), [Niina Korhonen](https://pubmed.ncbi.nlm.nih.gov/?term=Korhonen+N&cauthor_id=42713961)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42713961/#full-view-affiliation-4 "Department of Dermatology, Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland."), [Toni Karppinen](https://pubmed.ncbi.nlm.nih.gov/?term=Karppinen+T&cauthor_id=42713961)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42713961/#full-view-affiliation-5 "Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.") Affiliations Expand ### Affiliations * 1 Department of Dermatology, Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. petra.akerla@tuni.fi. * 2 Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland; Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland. * 3 Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland; Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland. * 4 Department of Dermatology, Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. * 5 Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. * PMID: **42713961** * DOI: [ 10.2340/actadv.v106.adv-2025-0274 ](https://doi.org/10.2340/actadv.v106.adv-2025-0274) Item in Clipboard # Narrow-band UV-B (TL-01) Phototherapy Exposure and Skin Cancer Risk: A Nested Case-control Study Petra Åkerla et al. Acta Derm Venereol. 2026. Show details Display options Display options Format Abstract PubMed PMID Acta Derm Venereol Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Acta+Derm+Venereol%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Acta+Derm+Venereol%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42713961/) . 2026 Sep 9:106. doi: 10.2340/actadv.v106.adv-2025-0274. ### Authors [Petra Åkerla](https://pubmed.ncbi.nlm.nih.gov/?term=%C3%85kerla+P&cauthor_id=42713961)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42713961/#short-view-affiliation-1 "Department of Dermatology, Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. petra.akerla@tuni.fi."), [Eero Pukkala](https://pubmed.ncbi.nlm.nih.gov/?term=Pukkala+E&cauthor_id=42713961)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42713961/#short-view-affiliation-2 "Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland; Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland."), [Mika Helminen](https://pubmed.ncbi.nlm.nih.gov/?term=Helminen+M&cauthor_id=42713961)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42713961/#short-view-affiliation-3 "Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland; Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland."), [Niina Korhonen](https://pubmed.ncbi.nlm.nih.gov/?term=Korhonen+N&cauthor_id=42713961)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42713961/#short-view-affiliation-4 "Department of Dermatology, Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland."), [Toni Karppinen](https://pubmed.ncbi.nlm.nih.gov/?term=Karppinen+T&cauthor_id=42713961)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42713961/#short-view-affiliation-5 "Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.") ### Affiliations * 1 Department of Dermatology, Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. petra.akerla@tuni.fi. * 2 Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland; Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland. * 3 Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland; Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland. * 4 Department of Dermatology, Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. * 5 Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. * PMID: **42713961** * DOI: [ 10.2340/actadv.v106.adv-2025-0274 ](https://doi.org/10.2340/actadv.v106.adv-2025-0274) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID ## Abstract Narrow-band TL-01 ultraviolet B phototherapy (TL-01) is generally considered a relatively safe treatment for skin diseases, although conflicting findings have also been reported. This study aimed to evaluate the association between TL-01 exposure and skin cancer risk using a nested case-control design within a Finnish cohort of 4,815 patients treated with TL-01 monotherapy, with subsequent 38 cases of basal cell carcinoma, 13 cases of cutaneous melanoma, and 9 cases of cutaneous squamous cell carcinoma. Four matched controls were selected for each skin cancer case. Personal TL-01 exposure data were obtained from hospital records. Conditional logistic regression was used to estimate odds ratios (ORs) and 95 % confidence intervals (CIs). An increased risk for basal cell carcinoma was observed with higher TL-01 exposure (OR per 20 sessions 1.36, 95% CI 1.08-1.72), whereas no association was found for cutaneous melanoma or cutaneous squamous cell carcinoma. In a categorical analysis, with category of 1-29 TL-01 sessions as the reference, the risk of basal cell carcinoma was markedly elevated among patients who received ≥60 sessions (OR 4.16, 95% CI 1.49-11.6). Occupational outdoor work was considered a potential confounder, but it had no effect. Further studies with larger cohorts and longer follow-up are needed to confirm these findings. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Similar articles * [ Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation. ](https://pubmed.ncbi.nlm.nih.gov/7726585/) Licata AG, Wilson LD, Braverman IM, Feldman AM, Kacinski BM.Licata AG, et al.Arch Dermatol. 1995 Apr;131(4):432-5.Arch Dermatol. 1995.PMID: 7726585Review. * [ Is ultraviolet exposure acquired at work the most important risk factor for cutaneous squamous cell carcinoma? Results of the population-based case-control study FB-181. ](https://pubmed.ncbi.nlm.nih.gov/28845516/) Schmitt J, Haufe E, Trautmann F, Schulze HJ, Elsner P, Drexler H, Bauer A, Letzel S, John SM, Fartasch M, Brüning T, Seidler A, Dugas-Breit S, Gina M, Weistenhöfer W, Bachmann K, Bruhn I, Lang BM, Bonness S, Allam JP, Grobe W, Stange T, Westerhausen S, Knuschke P, Wittlich M, Diepgen TL; FB-181 Study Group.Schmitt J, et al.Br J Dermatol. 2018 Feb;178(2):462-472. doi: 10.1111/bjd.15906. Epub 2018 Jan 15.Br J Dermatol. 2018.PMID: 28845516 * [ Ultraviolet radiation and risk of cutaneous melanoma and squamous cell carcinoma in males and females in the Norwegian Offshore Petroleum Workers cohort. ](https://pubmed.ncbi.nlm.nih.gov/33682179/) Liu FC, Grimsrud TK, Veierød MB, Robsahm TE, Ghiasvand R, Babigumira R, Shala NK, Stenehjem JS.Liu FC, et al.Am J Ind Med. 2021 Jun;64(6):496-510. doi: 10.1002/ajim.23240. Epub 2021 Mar 8.Am J Ind Med. 2021.PMID: 33682179 * [ In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. ](https://pubmed.ncbi.nlm.nih.gov/16368944/) Wang LE, Xiong P, Strom SS, Goldberg LH, Lee JE, Ross MI, Mansfield PF, Gershenwald JE, Prieto VG, Cormier JN, Duvic M, Clayman GL, Weber RS, Lippman SM, Amos CI, Spitz MR, Wei Q.Wang LE, et al.J Natl Cancer Inst. 2005 Dec 21;97(24):1822-31. doi: 10.1093/jnci/dji429.J Natl Cancer Inst. 2005.PMID: 16368944 * [ Occupational ultraviolet light exposure increases the risk for the development of cutaneous squamous cell carcinoma: a systematic review and meta-analysis. ](https://pubmed.ncbi.nlm.nih.gov/21054335/) Schmitt J, Seidler A, Diepgen TL, Bauer A.Schmitt J, et al.Br J Dermatol. 2011 Feb;164(2):291-307. doi: 10.1111/j.1365-2133.2010.10118.x.Br J Dermatol. 2011.PMID: 21054335 [ See all similar articles ](https://pubmed.ncbi.nlm.nih.gov/?linkname=pubmed_pubmed&from_uid=42713961) ## MeSH terms * Adult Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Adult%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Adult) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42713961/) * Aged Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Aged%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Aged) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42713961/) * Basal Cell Carcinoma* / diagnosis Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Basal+Cell+Carcinoma%2Fdiagnosis%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Basal+Cell+Carcinoma) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42713961/) * Basal Cell Carcinoma* / epidemiology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Basal+Cell+Carcinoma%2Fepidemiology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Basal+Cell+Carcinoma) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42713961/) * Basal Cell Carcinoma* / etiology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Basal+Cell+Carcinoma%2Fetiology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Basal+Cell+Carcinoma) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42713961/) * Carcinoma, Squamous Cell* / epidemiology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Carcinoma%2C+Squamous+Cell%2Fepidemiology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Carcinoma%2C+Squamous+Cell) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42713961/) * Carcinoma, Squamous Cell* / etiology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Carcinoma%2C+Squamous+Cell%2Fetiology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Carcinoma%2C+Squamous+Cell) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42713961/) * Case-Control Studies Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Case-Control+Studies%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Case-Control+Studies) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42713961/) * Cutaneous Squamous Cell Carcinoma Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cutaneous+Squamous+Cell+Carcinoma%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Cutaneous+Squamous+Cell+Carcinoma) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42713961/) * Female Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Female%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Female) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42713961/) * Finland / epidemiology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Finland%2Fepidemiology%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Finland) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42713961/) * Humans Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Humans%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Humans) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42713961/) * Logistic Models Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Logistic+Models%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Logist
## Related Clinical Research

- [Receptor-guided targeting of a melanoma-enriched noncanonical antigen (EVA003)](https://medichelpline.com/clinical-feed/pubmed-42706244.md) (DOI: 10.1038/s41392-026-02961-5)
- [Topical Resiquimod Primes CD8+ T Cells to Enhance Anti-PD-1 Response in Melanoma](https://medichelpline.com/clinical-feed/pubmed-42275481.md) (DOI: 10.1158/2326-6066.CIR-25-0998)
- [Cassidy report faults FDA oversight of mifepristone manufacturers](https://medichelpline.com/clinical-feed/stat-news-5-stat-cassidy-criticizes-fda-oversight-of-abortion-pill-manufacturers-in-new.md)
- [BINSA bill could protect U.S. biotech — but a loophole may enable ‘Eurowashing’](https://medichelpline.com/clinical-feed/stat-news-4-opinion-stat-a-bill-is-supposed-to-protect-u-s-biotech-from-chinese-competition.md)
- [Lived Experience in Rare Disease Research: Shaping Outcomes for Patients](https://medichelpline.com/clinical-feed/plos-medicine-0-living-with-a-rare-disease-why-lived-experience-must-shape-research.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.